Abstract
9004 Background: Combined blockade of T-cell checkpoints by NIVO and IPI demonstrated a high objective response rate (ORR), promising overall survival (OS), and a manageable safety profile in pts w...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have